167
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Simple HPLC-UV Method for Pharmacokinetic Studies of Imatinib in the Presence of Common Antimalaria Agents

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ayorinde Adehin, Babatunde A. Adeagbo, Martin A. Kennedy, Oluseye O. Bolaji, Tiwalade A. Olugbade, Rahman A. Bolarinwa & Muheez A. Durosinmi. (2019) Inter-individual variation in imatinib disposition: any role for prevalent variants of CYP1A2, CYP2C8, CYP2C9, and CYP3A5 in Nigerian CML patients?. Leukemia & Lymphoma 60:1, pages 216-221.
Read now

Articles from other publishers (4)

Jeffry Adiwidjaja, Annette S. Gross, Alan V. Boddy & Andrew J. McLachlan. (2021) Physiologically‐based pharmacokinetic model predictions of inter‐ethnic differences in imatinib pharmacokinetics and dosing regimens. British Journal of Clinical Pharmacology 88:4, pages 1735-1750.
Crossref
Babatunde Ayodeji Adeagbo, Tiwalade Adewale Olugbade, Muheez Alani Durosinmi, Rahman Ayodele Bolarinwa, Kayode Ogungbenro & Oluseye Oladotun Bolaji. (2017) Population Pharmacokinetics of Imatinib in Nigerians With Chronic Myeloid Leukemia: Clinical Implications for Dosing and Resistance. The Journal of Clinical Pharmacology 57:12, pages 1554-1563.
Crossref
B. A. Adeagbo, O. O. Bolaji, T. A. Olugbade, M. A. Durosinmi, R. A. Bolarinwa & C. Masimirembwa. (2016) Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia. Journal of Clinical Pharmacy and Therapeutics 41:5, pages 546-551.
Crossref
Iris Garrido-Cano, Aurelio Garc?a-Garc?a, Juan Peris-Vicente, Enrique Ochoa-Aranda & Josep Esteve-Romero. (2015) A method to quantify several tyrosine kinase inhibitors in plasma by micellar liquid chromatography and validation according to the European Medicines Agency guidelines. Talanta 144, pages 1287-1295.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.